Navigation Links
Isotechnika's Lead Drug, ISA247, To Be Highlighted at the,Association for Research in Vision and Ophthalmology (ARVO) Annual,Meeting

EDMONTON, Alberta, May 4, 2007 – Isotechnika Inc. (TSX:ISA) announced today that the Company’s lead drug, ISA247, referred to as LX211 by our partner Lux Biosciences, has been selected as the subject of two presentations at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, being held May 6-10 in Fort Lauderdale, Florida.

The first, an oral presentation being given on May 5 during a satellite session of the American Uveitis Society by Dr. Quan Dong Nguyen, Johns Hopkins University, discusses the ongoing LUMINATE (Lux Uveitis Multicenter Investigation of a New Approach to TrEatment) Phase 2/3 Clinical Trial Program. The three LUMINATE trials represent the first clinical development program aimed at supporting regulatory approval of a corticosteroid-sparing immunosuppressive agent in different types of sight-threatening, non-infectious uveitis.

The second, a poster presented by Matthew A. Cunningham, National Eye Institute, discusses preclinical data demonstrating the ability of subcutaneous injections of LX211 to prevent and reverse experimental autoimmune uveoretinitis (EAU) in rats. Cunningham commented, “We observed that in this animal model, LX211 could both prevent the onset of disease as well as reverse EAU at doses as low as 10mg/kg. These preclinical results clearly support our view that LX211 may play an important future role in the treatment of uveitis.”

“These positive preclinical results, combined with encouraging safety data from human clinical trials in other indications conducted by our partner Isotechnika, provide a strong rationale for our ongoing registration-directed LUMINATE studies of LX211 in uveitis,” said Ulrich Grau, Ph.D., Lux Biosciences’ president and chief executive officer. “We hope to complete enrollment in the LUMINATE trial program by early 2008 and, if suc
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Isotechnikas independent data monitoring committee conducts review of phase 2b kidney transplant trial
2. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
3. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
4. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
5. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
6. Gentiums Defibrotide Highlighted in Two Poster Presentations at American Association for Cancer Research Annual Meeting
7. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
8. NIEHS Researchers Identify Enzyme Critical in DNA Replication
9. Stanford Researchers Find Brain Pathway of Depression in Rats
10. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
11. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
Post Your Comments:
(Date:4/24/2015)...  Bayer Corporation hosted its annual "Take Your Child to ... US headquarters.  This is Bayer,s second "Take Your Child To ... campus, and Thursday,s event welcomed 230 children ready to ... Fortunately, for the kids, this was not just ... is "Science For A Better Life," Bayer made sure that ...
(Date:4/24/2015)... CHAPEL HILL, N.C. , April 24, 2015 ... marketplace, organizations are establishing employee groups around the ... workforce and round-the-clock business hours. While there are ... becoming global, leaders must examine which best practices ... global operational excellence. According to ...
(Date:4/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/pmbmv2/global_biobanking ) has ... 2015-2019" report to their offering. The ... a CAGR of 7.07% over the period 2014-2019 ... two segments: Equipment and Consumables. This report covers the ... Biobanking market for the period 2015-2019. ...
Breaking Medicine Technology:Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4Work Around the Clock: Building Effective Global Capabilities 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2
... ANGELES, Oct. 13, 2011 IVD Technology ... in vitro diagnostics technologies including research, development, and manufacturing, ... most significant emerging trend in the industry ... (CONTACT:   http://photos.prnewswire.com/prnh/20101214/LA16070LOGO ) The ...
... Oct. 13, 2011 PharmAthene, Inc. (NYSE Amex: ... brief in response to SIGA Technologies, motion for reargument.  On ... Chancery had issued a ruling in its litigation against SIGA ... years from all sales of ST-246 and related products after ...
Cached Medicine Technology:Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 2Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 3PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument 2PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument 3
(Date:4/25/2015)... York New York (PRWEB) April 25, 2015 ... that Dr. Jerry Blaivas has been chosen by the New ... for his contributions to medicine in the field of Urology. ... the best in his speciality, Genito-Urinary diseases. He was ... specifically in the field of urology. Not only did ...
(Date:4/25/2015)... On Friday, April 17, Interstate Batteries ... Best Implementation Award. This award is given to ... of RFID technology to improve its manufacturing, supply chain ... best demonstrates how RFID is delivering real value to ... Live! 2015 in San Diego, the RFID industries annual ...
(Date:4/24/2015)... CA (PRWEB) April 24, 2015 Bird B ... and residential applications now offers a complete line of bird ... to poultry farms. , New Flu Strains Threaten Pacific, Central ... 2015 USDA post , a number of highly pathogenic ... paths. The disease is often spread when wild birds enter ...
(Date:4/24/2015)... April 24, 2015 Multi Customer Discount ... tank pumping ( http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 gallons in ... the program. This does not include any Dig fees, ... $25-$65 per person. If someone is part of this ... tanks totaling approximately 2500 gallons or more, the cost ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Ryadon is ... wide range of capabilities and services to complement any ... Ryadon's Quantity Discount Program will be offered on all ... , Order 4-19: Receive 10% discount - Order 20+: ... Using the Drawer Slides Products, ...
Breaking Medicine News(10 mins):Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3
... the 25 years since establishing the Dyslexia Research Laboratory ... MD, has witnessed a dramatic transformation in thinking among ... years, there have been a host of explanations offered ... of Behavioral Neurology at BIDMC whose work has played ...
... Oct. 17 SuperGen Inc.,(Nasdaq: SUPG ), ... and commercialization of therapies for solid tumors and,hematological ... for poster presentations at the AACR-NCI-EORTC International,Conference from ... Francisco. The poster presentations will focus on ...
... platform that,leverages data contained within enterprise healthcare systems into clinical, intelligence ... ... costs, PHILADELPHIA, ... availability of the NDMA Clinical,Intelligence Platform to all healthcare providers around ...
... ATLANTA, Oct. 17 After completing its review ... Data Safety,Monitoring Board (DSMB) has recommended that the ... Diabetic Macular Edema) Study,continue under the current protocol, ... Medidur FA for the treatment of diabetic macular ...
... physician,you hear all sorts of excuses for not getting ... of First Coast Family Medicine and clinical,spokesperson for Jacksonville,s ... Dr. Hashey reports is the excuse that people always,get ... farther from the truth.,The flu shot is safe and ...
... Systems,Incorporated (Nasdaq: IMCL ) and Bristol-Myers Squibb ... have established an agreement with Merck KGaA for,the ... the terms of the agreement, ImClone Systems, Bristol-Myers,Squibb ... effort to develop and,following regulatory approval, market ERBITUX ...
Cached Medicine News:Health News:BIDMC Dyslexia Research Lab celebrates 25th anniversary 2Health News:SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference 2Health News:SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference 3Health News:NDMA Launches Clinical Intelligence Platform 2Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 2Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 3Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 4Health News:Flu Myths Abound in Flu Season 2Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 2Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 3Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 4Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 5Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 6Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 7
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
Medicine Products: